Prevention of ischemic stroke

被引:4
作者
Jesse Weinberger
机构
[1] The Mount Sinai School of Medicine,Department of Neurology
关键词
Warfarin; Ischemic Stroke; Clopidogrel; Transient Ischemic Attack; Ticlopidine;
D O I
10.1007/s11936-002-0019-z
中图分类号
学科分类号
摘要
The primary risk factors for stroke are known, and attention to primary care of these disorders should reduce the incidence of stroke significantly. Control of hypertension, diabetes, and hyperlipidemia have all been shown to reduce the rate of stroke. Identification of potential cardioembolic sources of stroke, particularly atrial fibrillation, can prevent stroke with appropriate application of anticoagulation. Duplex Doppler B-mode sonography can establish the extent of carotid artery disease in patients with cervical bruit or risk factors for atherosclerosis, and indicate which conditions should be managed medically or surgically. Patients with a history suggestive of transient ischemic attacks can also be screened noninvasively with duplex sonography to determine if they have a critical carotid stenosis and require carotid endarterectomy. New advances in platelet antiaggregant therapy with ticlopidine, clopidogrel, and the combination of aspirin with dipyridamole have also reduced the rate of stroke to a greater degree than standard treatment with aspirin. The incidence of this devastating illness could possibly be reduced by 50% with attentive primary care management. The cardiologist is often involved in the treatment of patients at risk for stroke, and is in an ideal position to provide this care.
引用
收藏
页码:393 / 403
页数:10
相关论文
共 50 条
[11]   Ischemic stroke prevention: An update on antiplatelet therapy [J].
Neill, KK ;
Luer, MS .
NEUROLOGICAL RESEARCH, 2002, 24 (04) :381-388
[12]   Dabigatran pharmacogenetics and secondary prevention of ischemic stroke [J].
Olserova, A. ;
Jansky, P. ;
Sramkova, T. ;
Tomek, A. .
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (04) :281-286
[13]   Antiplatelet agents for secondary prevention of ischemic stroke [J].
Majid, A ;
Delanty, N ;
Kantor, J .
ANNALS OF PHARMACOTHERAPY, 2001, 35 (10) :1241-1247
[14]   Antiplatelet medications in the secondary prevention of ischemic stroke [J].
James D. Fleck .
Current Neurology and Neuroscience Reports, 2005, 5 (1) :1-3
[15]   Primary Prevention of Ischemic Stroke [J].
Sabayan, Behnam .
SEMINARS IN NEUROLOGY, 2022, 42 (05) :571-582
[16]   Causes and Secondary Prevention of Acute Ischemic Stroke in Adults [J].
Jensen, Maerit ;
Thomalla, Goetz .
HAMOSTASEOLOGIE, 2020, 40 (01) :22-30
[17]   Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure [J].
Lusk, Jay B. ;
Xu, Haolin ;
Peterson, Eric D. ;
Bhatt, Deepak L. ;
Fonarow, Gregg C. ;
Smith, Eric E. ;
Matsouaka, Roland ;
Schwamm, Lee H. ;
Xian, Ying .
STROKE, 2021, 52 (12) :E777-E781
[18]   Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review [J].
Valis, Martin ;
Klimova, Blanka ;
Novotny, Michal ;
Herzig, Roman .
FRONTIERS IN NEUROLOGY, 2021, 12
[19]   ANTIPLATELET THERAPY IN THE PREVENTION OF ISCHEMIC STROKE [J].
VERRY, M ;
PANAK, E ;
CAZENAVE, JP .
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1994, 36 (03) :213-228
[20]   Primary and Secondary Prevention of Ischemic Stroke [J].
Paciaroni, Maurizio ;
Bogousslavsky, Julien .
EUROPEAN NEUROLOGY, 2010, 63 (05) :267-278